CLINICAL_TRIALS
trial_result
· 2020-06-29
Clinical Trial Update: HFNC Effect on BCSS in Patients With COPD [NA]
Summary
Clinical trial update on high-flow nasal cannula (HFNC) effect on BCSS in COPD patients; study terminated with results posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Oklahoma | Conditions: Chronic Obstructive Pulmonary Disease | NA | Status: TERMINATED | Results posted: 2020-06-29